Dupuis, L. L., Fisher, B. T., Sugalski, A. J., Grimes, A. C., Nuño, M., Ramakrishnan, S., Beauchemin, M. P., Robinson, P. D., Santesso, N., Walsh, A., Wrightson, A. R., Yu, L., Parsons, S. K., & Sung, L. (2024). Clinical practice guideline‐inconsistent management of fever and neutropenia in pediatric oncology: A Children’s Oncology Group study. Pediatric Blood & Cancer, 71(4). Portico. https://doi.org/10.1002/pbc.30880

O’Neil, D. S., Martei, Y. M., Crew, K. D., Castillo, B. S., Costa, P., Lim, T., Michel, A., Rubin, E., Goel, N., Hurley, J., Lopes, G., & Antoni, M. H. (2023). Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV. JAMA Network Open, 6(12), e2346223. https://doi.org/10.1001/jamanetworkopen.2023.46223

Szymczak, J. E., Getz, K. D., Madding, R., Shuster, S., Aftandilian, C., Arnold, S. D., Collier, A. B., Gramatges, M. M., Henry, M., Hijiya, N., Mian, A., Raetz, E., Fisher, B. T., & Aplenc, R. (2023). Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemia. Pediatric Blood & Cancer, 70(8). Portico. https://doi.org/10.1002/pbc.30420

Lehrnbecher, T., Robinson, P. D., Ammann, R. A., Fisher, B., Patel, P., Phillips, R., Beauchemin, M. P., Carlesse, F., Castagnola, E., Davis, B. L., Elgarten, C. W., Groll, A. H., Haeusler, G. M., Koenig, C., Santolaya, M. E., Tissing, W. J. E., Wolf, J., Alexander, S., Hu, H., … Sung, L. (2023). Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update. Journal of Clinical Oncology, 41(9), 1774–1785. https://doi.org/10.1200/jco.22.02224

Conte, M. I., Poli, M. C., Taglialatela, A., Leuzzi, G., Chinn, I. K., Salinas, S. A., Rey-Jurado, E., Olivares, N., Veramendi-Espinoza, L., Ciccia, A., Lupski, J. R., Aldave Becerra, J. C., Mace, E. M., & Orange, J. S. (2022). Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia. JCI Insight, 7(21). https://doi.org/10.1172/jci.insight.154948

Braghieri, L., Jennings, D. L., Bohn, B., Habal, M., Pinsino, A., Mondellini, G. M., Ladanyi, A., Latif, F., Clerkin, K., Restaino, S., Kurlansky, P., Takeda, K., Naka, Y., Demmer, R. T., Sayer, G. T., Uriel, N., Colombo, P. C., & Yuzefpolskaya, M. (2022). Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 42(9), 697–706. Portico. https://doi.org/10.1002/phar.2724

Diamond, J. R., Boni, V., Lim, E., Nowakowski, G., Cordoba, R., Morillo, D., Valencia, R., Genvresse, I., Merz, C., Boix, O., Frigault, M. M., Greer, J. M., Hamdy, A. M., Huang, X., Izumi, R., Wong, H., & Moreno, V. (2022). First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy. Clinical Cancer Research, 28(7), 1285–1293. https://doi.org/10.1158/1078-0432.ccr-21-3617